Investor Woodford calls for outsider to head GlaxoSmithKline
LONDON (Reuters) - Fund manager Neil Woodford, a top investor in GlaxoSmithKline and a critic of the drugmaker's current structure, said on Thursday he wanted to see an outsider replace Andrew Witty as the group's chief executive.
No comments:
Post a Comment